{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:29:39Z","timestamp":1787243379514,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.crad.2026.107417","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:51:32Z","timestamp":1781797892000},"page":"107417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Machine learning using T2-weighted radiomics for International Society of Urological Pathology (ISUP) classification in prostate cancer"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8742-1818","authenticated-orcid":false,"given":"V.A.","family":"Ohannesian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5486-9037","authenticated-orcid":false,"given":"M.X.S.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3626-3334","authenticated-orcid":false,"given":"L.A.P.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0792-1211","authenticated-orcid":false,"given":"M.J.","family":"Francisco Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-9595","authenticated-orcid":false,"given":"R.G.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crad.2026.107417_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.crad.2026.107417_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"6","key":"10.1016\/j.crad.2026.107417_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol."},{"issue":"2","key":"10.1016\/j.crad.2026.107417_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"22","key":"10.1016\/j.crad.2026.107417_bib5","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.crad.2026.107417_bib6","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2026.107417_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1756287219870074","article-title":"A review of optimal prostate biopsy: indications and techniques","volume":"11","author":"Streicher","year":"2019","journal-title":"Ther Adv Urol"},{"issue":"6","key":"10.1016\/j.crad.2026.107417_bib8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.crad.2026.107417_bib29","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.acra.2024.12.006","article-title":"MRI-based radiomics for predicting prostate cancer grade groups: a systematic review and meta-analysis of diagnostic test accuracy studies","volume":"32","author":"Lomer","year":"2025","journal-title":"Acad Radiol"},{"key":"10.1016\/j.crad.2026.107417_bib30","first-page":"1","article-title":"Artificial-intelligence models vs. radiologists in the detection of clinically significant prostate cancer on mpMRI: a meta-analysis","author":"Andrade","year":"2026","journal-title":"Eur Radiol"},{"issue":"17","key":"10.1016\/j.crad.2026.107417_bib9","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2026.107417_bib10","series-title":"StatPearls [internet]","article-title":"Prostate-specific antigen. [updated 2024 sep 10]","author":"David","year":"2025"},{"issue":"3","key":"10.1016\/j.crad.2026.107417_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cncr.31140","article-title":"Prostate cancer screening with prostate-specific antigen: where are we going?","volume":"124","author":"Albertsen","year":"2018","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.crad.2026.107417_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00345-024-04776-x","article-title":"PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions","volume":"42","author":"Kwe","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.crad.2026.107417_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canep.2017.12.002","article-title":"Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: a UK case study","volume":"52","author":"Leal","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"10.1016\/j.crad.2026.107417_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.21037\/tau.2017.12.31","article-title":"MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?","volume":"7","author":"Schoots","year":"2018","journal-title":"Transl Androl Urol"},{"issue":"6","key":"10.1016\/j.crad.2026.107417_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21681805.2016.1206619","article-title":"Interobserver variability in gleason histological grading of prostate cancer","volume":"50","author":"Ozkan","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.crad.2026.107417_bib16","author":"Litjens"},{"issue":"4","key":"10.1016\/j.crad.2026.107417_bib17","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.240300","article-title":"Checklist for artificial intelligence in medical imaging (CLAIM): 2024 update","volume":"6","author":"Tejani","year":"2024","journal-title":"Radiol Artif Intell"},{"issue":"17","key":"10.1016\/j.crad.2026.107417_bib18","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.3390\/cancers16172944","article-title":"MRI T2w radiomics-based machine learning models in imaging simulated biopsy add diagnostic value to PI-RADS in predicting prostate cancer: a retrospective diagnostic study","volume":"16","author":"Liu","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"33","key":"10.1016\/j.crad.2026.107417_bib22","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1200\/JCO.2012.45.4801","article-title":"Psychological impact of prostate biopsy: physical symptoms, anxiety, and depression","volume":"31","author":"Wade","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2026.107417_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2024.06.015","article-title":"Risk factors for infection after transrectal prostate biopsy: a population-based register study","volume":"67","author":"\u00d6rtegren","year":"2024","journal-title":"Eur Urol Open Sci"},{"issue":"6","key":"10.1016\/j.crad.2026.107417_bib24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","article-title":"Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus -based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy","volume":"4","author":"Panebianco","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.crad.2026.107417_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00330-019-06488-y","article-title":"Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer","volume":"30","author":"Bleker","year":"2020","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.crad.2026.107417_bib19","first-page":"29","article-title":"What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?","volume":"10","author":"Zhao","year":"2023","journal-title":"Mil Med Res"},{"issue":"19","key":"10.1016\/j.crad.2026.107417_bib20","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.crad.2026.107417_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2026.107417_bib26","article-title":"Explainable artificial intelligence (XAI) in radiology and nuclear medicine: a literature review","volume":"10","author":"de Vries","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.crad.2026.107417_bib27","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1007\/s00330-022-08712-8","article-title":"A deep learning masked segmentation alternative to manual segmentation in biparametric MRI prostate cancer radiomics","volume":"32","author":"Bleker","year":"2022","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.crad.2026.107417_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jmri.25372","article-title":"Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: a multireader study","volume":"45","author":"Greer","year":"2017","journal-title":"J Magn Reson Imaging"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026001935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026001935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:17:07Z","timestamp":1787242627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026001935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0009926026001935"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107417","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning using T2-weighted radiomics for International Society of Urological Pathology (ISUP) classification in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107417"}}